MedTrace Logo

Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula

NCT06029569 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 256

Last updated 2023-09-08

No results posted yet for this study

Summary

Verify the effectiveness and safety of rapamycin coated balloon dilation catheter for the treatment of dialysis pathway stenosis or blockage lesions.

Conditions

  • Peripheral Arterial Disease

Interventions

PROCEDURE

Rapamycin drug balloon angioplasty

Rapamycin drug balloon treatment for stenosis or blockage of the dialysis pathway in autologous arteriovenous fistula.

PROCEDURE

Paclitaxel drug balloon angioplasty

Paclitaxel drug balloon therapy for stenosis or blockage of the dialysis pathway of autologous arteriovenous fistula.

Sponsors & Collaborators

  • Shanghai Bomaian Medical Technology Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-15
Primary Completion
2025-09-15
Completion
2025-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06029569 on ClinicalTrials.gov